Similar Papers

Paper Title
Journal
Date
Author
SARS-CoV-2 Booster Vaccination for Participants in "HIV Cure"-Related Clinical Trials.
Michael J Peluso ... Lynn H Ngo
Journal of acquired immune deficiency syndromes (1999) | VOL. 89
Michael J Peluso, et. al.Michael J Peluso ... Lynn H Ngo
01 Mar 2022
Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure.
James R Hunter ... Hong-Ha M Truong
Pathogens | VOL. 10
James R Hunter, et. al.James R Hunter ... Hong-Ha M Truong
03 Nov 2021
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption.
Marie-Angélique De Scheerder ... Filip Van Wanzeele
Journal of Antimicrobial Chemotherapy | VOL. 75
Marie-Angélique De Scheerder, et. al.Marie-Angélique De Scheerder ... Filip Van Wanzeele
13 Feb 2020
Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control.
Anshika Jain ... Bushirat M Balogun
Frontiers in medicine | VOL. 11
Anshika Jain, et. al.Anshika Jain ... Bushirat M Balogun
14 May 2024
View more papers

More From: Nature Immunology

Paper Title
Journal
Date
Author
Author Correction: Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption
Susan Pereira Ribeiro ... Rafick P Sekaly
Nature Immunology | VOL. -
Susan Pereira Ribeiro, et. al.Susan Pereira Ribeiro ... Rafick P Sekaly
16 Jan 2025
Differential roles of human CD4+ and CD8+ regulatory T cells in controlling self-reactive immune responses.
Xin Chen ... Mark M Davis
Nature immunology | VOL. -
Xin Chen, et. al.Xin Chen ... Mark M Davis
13 Jan 2025
Low-avidity T cells drive endogenous tumor immunity in mice and humans.
Summit Singhaviranon ... Pramod K Srivastava
Nature immunology | VOL. -
Summit Singhaviranon, et. al.Summit Singhaviranon ... Pramod K Srivastava
09 Jan 2025
IRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programs.
Brendan M Barton ... Stanley Adoro
Nature immunology | VOL. -
Brendan M Barton, et. al.Brendan M Barton ... Stanley Adoro
09 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.